ArticlePloS one2017

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.

Shih-Hung Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.